Journal articles
Barnish M, Tan SY, Taeihagh A, Robinson S, Melendez-Torres GJ (In Press). A realist synthesis to develop an explanatory model of how policy instruments impact child and maternal health outcomes. Social Science & Medicine
Society for Social Medicine and Population Health ECR Subcommittee, Hayes CB (In Press). Early career researchers’ thoughts on academic careers: updated evidence from the Society for Social Medicine and Population Health. Journal of Epidemiology and Community Health
Trigg LA, Barnish MS, Hayward S, Shaw N, Crathorne L, Groves B, Spoors J, Strong T, Melendez-Torres GJ, Farmer C, et al (2024). An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund.
Pharmacoecon Open,
8(2), 303-311.
Abstract.
Author URL.
Farmer C, Barnish MS, Trigg LA, Hayward S, Shaw N, Crathorne L, Strong T, Groves B, Spoors J, Melendez Torres GJ, et al (2023). An evaluation of managed access agreements in England based on stakeholder experience.
International Journal of Technology Assessment in Health Care,
39(1).
Abstract.
Farmer C, O’Toole B, Barnish MS, Trigg LA, Hayward S, Crathorne L, Kasten Z, Spoors J, Melendez-Torres GJ (2023). Early access schemes for innovative health technologies: the views of international stakeholders.
International Journal of Technology Assessment in Health Care,
39(1).
Abstract.
Jones ML, Barnish MS, Hughes RR, Murray AK, Mansour O, Loni T, Vickery HM, Evans ML, Green L, Verdezoto N, et al (2023). Exploring the potential of using simulation games for engaging with sheep farmers about lameness recognition.
Front Vet Sci,
10 Abstract.
Author URL.
Barnish MS, Nelson-Horne RV (2023). Group-based active artistic interventions for adults with primary anxiety and depression: a systematic review.
BMJ Open,
13(6), e069310-e069310.
Abstract.
Ghiasvand H, Barnish MS, Moradi T, Nikram E, Naghdi S (2022). Making orphan drugs and services available and accessible for people who live with rare diseases: what has been done? a systematic scoping review.
EXPERT OPINION ON ORPHAN DRUGS,
10(1), 55-64.
Author URL.
Barnish MS, Tan SY, Taeihagh A, Tørnes M, Nelson-Horne RVH, Melendez-Torres GJ (2021). Linking political exposures to child and maternal health outcomes: a realist review.
BMC Public Health,
21(1).
Abstract.
Barnish MS, Barran SM (2020). A systematic review of active group-based dance, singing, music therapy and theatrical interventions for quality of life, functional communication, speech, motor function and cognitive status in people with Parkinson’s disease.
BMC Neurology,
20(1).
Abstract.
Barnish M, Daley DJ, Deane KHO, Clark AB, Gray RJ, Horton SMC, Butterfint ZR, Myint PK (2019). Cognitive profile and determinants of poor cognition in people without dementia in Parkinson's disease. Medical Journal of the Islamic Republic of Iran, 33
Whibley D, AlKandari N, Kristensen K, Barnish M, Rzewuska M, Druce KL, Tang NKY (2019). Sleep and Pain: a Systematic Review of Studies of Mediation.
Clin J Pain,
35(6), 544-558.
Abstract.
Author URL.
Varley-Campbell J, Mujica Mota R, Coelho H, Ocean N, Barnish M, Packman D, Dodman S, Cooper C, Snowsill TM, Kay T, et al (2019). Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation. Health Technology Assessment, 23(13).
Barnish M, Tørnes M, Nelson-Horne B (2018). How much evidence is there that political factors are related to population health outcomes? an internationally comparative systematic review. BMJ Open, 8, e020886-e020886.
Barnish M (2018). The inclusion of retracted studies in systematic reviews: a response to Gray et al. (2018). International Journal of Nursing Studies, 80, 90-91.
Barnish MS, Tagiyeva N, Devereux G, Aucott L, Turner S (2017). Changes in the relationship between asthma and associated risk factors over fifty years.
Pediatric Allergy and Immunology,
28(2), 162-169.
Abstract.
Macfarlane GJ, Barnish MS, Pathan E, Martin KR, Haywood KL, Siebert S, Packham J, Atzeni F, Jones GT (2017). Co‐Occurrence and Characteristics of Patients with Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia.
Arthritis & Rheumatology,
69(11), 2144-2150.
Abstract.
Macfarlane GJ, Barnish MS, Jones GT (2017). Persons with chronic widespread pain experience excess mortality: longitudinal results from UK Biobank and meta-analysis.
Ann Rheum Dis,
76(11), 1815-1822.
Abstract.
Author URL.
Barnish MS, Horton SMC, Butterfint ZR, Clark AB, Atkinson RA, Deane KHO (2017). Speech and communication in Parkinson’s disease: a cross-sectional exploratory study in the UK.
BMJ Open,
7(5), e014642-e014642.
Abstract.
Barnish M, Morgan HM, Barnish J (2017). The 2016 HIGh Heels: Health effects and psychosexual BenefITS (HIGH HABITS) study: systematic review of reviews and additional primary studies. BMC Public Health, 18(1).
Reynolds SE, Richardson SV, Barnish M, Reid I, Ross R, Campbell R, Horne B (2017). The Politics of Women’s Fashion in the Cultural West: a Perspective. Art and Design Review, 5, 252-257.
Barnish MS, Turner S (2017). The value of pragmatic and observational studies in health care and public health.
Pragmat Obs Res,
8, 49-55.
Abstract.
Author URL.
Barnish MS, Barnish J (2016). High-heeled shoes and musculoskeletal injuries: a narrative systematic review.
BMJ Open,
6(1).
Abstract.
Author URL.
Barnish J, Atkinson RA, Barran SM, Barnish MS (2016). Potential Benefit of Singing for People with Parkinson's Disease: a Systematic Review.
JOURNAL OF PARKINSONS DISEASE,
6(3), 473-484.
Author URL.
Barnish MS, Whibley D, Horton SMC, Butterfint ZR, Deane KHO (2016). Roles of Cognitive Status and Intelligibility in Everyday Communication in People with Parkinson's Disease: a Systematic Review.
JOURNAL OF PARKINSONS DISEASE,
6(3), 453-462.
Author URL.
Barnish MS, Tagiyeva N, Devereux G, Aucott L, Turner S (2015). Diverging prevalences and different risk factors for childhood asthma and eczema: a cross-sectional study.
BMJ Open,
5(6).
Abstract.
Author URL.
Macfarlane GJ, Barnish MS, Jones EA, Kay L, Keat A, Meldrum KT, Pathan E, Sturrock RD, Zabke C, McNamee P, et al (2015). The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment.
BMC Musculoskelet Disord,
16 Abstract.
Author URL.
Barnish M (2014). A quantitative content analysis of person-first language use in healthcare research, healthcare practice, and by support groups for people with disabilities. Open Journal of Modern Linguistics, 4, 505-511.
Reports
O'Toole B, Muthukumar M, Robinson S, Lowe J, Melendez-Torres GJ, Barnish M (2023). Axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
Barnish M, Muthukumar M, Lovell A, Abdelsabour A, McBride P, Perks J, Farmer C, Wilson E, Dawes H, Melendez-Torres GJ, et al (2023). Digital pulmonary rehabilitation technologies for adults with chronic obstructive pulmonary disease [GID-HTE10019].
Barnish M, O'Toole B, Nikram E, Matthews J, Robinson S, Abdelsabour A, Knapper S, Wilson E (2023). Ivosidenib with azacitidine for untreated IDH1-positive acute myeloid leukaemia: a Single Technology Appraisal.
Lee D, Muthukumar M, Lovell A, Farmer C, Burns D, Matthews J, Coelho H, O'Toole B, Trigg L, Snowsill T, et al (2023). Treatments for renal cell carcinoma [ID 6186]: a pathways pilot appraisal.
Barnish M, Lovell A, Robinson S, Nikram E, Farmer C, Wilson E (2023). Virtual reality for treating agoraphobia and agoraphobic avoidance: early value assessment [MT725].
Barnish M, Sullivan W, Matthews J, Day C, Robinson S, Long L, Phillips Z, Dorey N (2022). Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer.
Barnish M, Lee D, Robinson S, Sadik A, Brand A, Trigg L, Wilson E (2022). Digitally enabled therapies for adults with depression [MTG588].
O'Toole B, Barnish M, Wilson E, Matthews J, Coelho H, Shaw N, et al. (2022). Pembrolizumab with lenvatinib for previously treated advanced, metastatic or recurrent endometrial cancer. NICE.
Barnish M, Robinson S, Trigg L, Wilson E (2022). Review report of MTG42, UrgoStart for treating diabetic foot ulcers and leg ulcers.
Barnish M, Naik J, Sullivan W, Brand A, Hook E, Matthews J, Edmonson-Jones M, et al (2022). Risankizumab for previously treated moderately to severely active Crohn's disease.
Farmer C, O'Toole B, Barnish M, Trigg L, Hayward S, Crathorne L, Melendez-Torres GJ (2021). A Strategic Approach to Early Access Schemes:. Results.
Farmer C, Barnish M, Trigg L, Shaw N, Hayward S, Crathorne L, Melendez-Torres GJ (2021). Findings from a quantitative and qualitative evaluation of managed access agreements in the UK.
Barnish M, Brian O, Packman D, Muthukumar M, Matthews J, Shaw N, Rudin CE, Crathrone L, Melendez-Torres G (2021). Pembrolizumab for treating relapsed or. refractory classical Hodgkin’s lymphoma after. 1 or more multi-agent chemotherapy. regimens:. a Single Technology Appraisal. NICE.
Bullement A, Barnish M, Slater R, Shaw N, Matthews J, Crathorne L, Long L, Melendez-Torres G (2021). Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer.
Brand A, Muthukumar M, Barnish M, O'Toole B, Trigg L, Robinson S, Tan T, O'Rahilly S, Melendez-Torres GJ, Crathorne L, et al (2021). Setmelanotide for treating obesity caused by LEPR or POMC deficiency [ID3764].
Barnish M, Cummins E, Coelho H, Johnston R, Packman D, Shaw N, Haigh R, Crathorne L, Melendez-Torres GJ (2020). Upadacitinib for treating moderate to severe rheumatoid arthritis [ID1400]: a Single Technology Appraisal. NICE.
Tikhonova I, Long L, Ocean N, Barnish M, Robinson S, Nikram E, Bello S, Dodman S, Halpin D, Hoyle M, et al (2018). Benralizumab for treating severe asthma: a Single Technology Appraisal.
Varley-Campbell J, Mujica-Mota R, Coelho H, Ocean N, Barnish M, Packman D, Dodman S, Cooper C, Snowsill T, Kay T, et al (2018). Biomarker tests to help diagnose preterm labour in women with intact membranes. NICE.
Griffin E, Barnish M, Packman D, Coelho H, Matthews J, Dodman S, Robinson S, Dangoor A, Dorey N, Hoyle M, et al (2018). Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib: a Single Technology Appraisal. NICE.
Griffin E, Farmer C, Packman D, Nikram E, Matthews J, Barnish M, Briscoe S, Dorey N, Dangoor A, Mujica Mota R, et al (2018). Pembrolizumab with pemetrexed and platinum chemotherapy for untreated metastatic non-squamous non-small-cell lung cancer [ID1173]: a Single Technology Appraisal. NICE.
Barnish M, Morgan HM (2017). Are high heels bad for your health? Two experts review the evidence. The Conversation.
Barnish M (2013). Relationships between cognitive status, speech impairment and communicative participation in Parkinson’s disease. University of East Anglia.